Noriyuki Suzuki
Asahi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.
Journal: The Prostate
Published: February 03, 2026
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.
Journal: BJU international
Published: November 13, 2025
Efficacy of preventive skin moisturization for dermatological adverse events caused by apalutamide: A retrospective study at 2 facilities in Japan.
Journal: Dermatology online journal
Published: November 07, 2025
Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy.
Journal: Anticancer research
Published: October 28, 2025
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.
Journal: Japanese journal of clinical oncology
Published: March 26, 2025
Upfront Androgen Receptor-Axis-Targeted Therapies in Men with De Novo High-Volume Metastatic Hormone-Sensitive Prostate Cancer.
Journal: Urology journal
Published: March 12, 2023
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy.
Journal: Asian journal of andrology
Published: May 08, 2018
Micropatterning of Multiple Photonic Colloidal Crystal Gels for Flexible Structural Color Films.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: May 24, 2017
Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis.
Journal: Prostate international
Published: February 18, 2017
Treatment of locally advanced prostate cancer (Stage T3).
Journal: Japanese journal of clinical oncology
Published: September 19, 2016
Last Updated: 09/26/2026